<span item_type="fundamental" item_id="c0fa7d1d053fe6b7c677d95a11289b45" counter_id="ST/US/NHC" env="prod"></span><span item_type="announcement" item_id="646129620953597697" env="prod"></span><p>Revenue: As of FY2026 Q1, the actual value is USD 381.82 M.</p><p>EPS: As of FY2026 Q1, the actual value is USD 2.27.</p><p></p><h3>Financial and Operational Metrics for National HealthCare Corporation</h3><h4>Segment Revenue</h4><p>Net operating revenues for the quarter ended March 31, 2026, totaled $381,821,000, marking a 2.2% increase compared to $373,697,000 for the same period in 2025. Net patient revenues were $369,805,000 in Q1 2026, up from $361,607,000 in Q1 2025. Other revenues slightly decreased to $12,016,000 in Q1 2026 from $12,090,000 in Q1 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1047335/000143774926015802/ex_958378.htm"></span></p><h4>Net Income</h4><p>GAAP net income attributable to National HealthCare Corporation was $35,857,000 for Q1 2026, compared to $32,205,000 for Q1 2025. Adjusted net income, excluding unrealized gains on marketable equity securities and other non-GAAP adjustments, increased by 21.1% to $30,089,000 in Q1 2026 from $24,838,000 in Q1 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1047335/000143774926015802/ex_958378.htm"></span></p><h4>Operating Expenses</h4><p>Total costs and expenses for Q1 2026 were $349,568,000, up from $342,930,000 in Q1 2025. Key components include: salaries, wages, and benefits at $235,074,000 in Q1 2026 versus $228,130,000 in Q1 2025; other operating expenses at $91,237,000 in Q1 2026 versus $92,457,000 in Q1 2025; facility rent at $11,643,000 in Q1 2026 versus $11,365,000 in Q1 2025; and depreciation and amortization at $11,614,000 in Q1 2026 versus $10,978,000 in Q1 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1047335/000143774926015802/ex_958378.htm"></span></p><h4>Income from Operations</h4><p>Income from operations rose to $32,253,000 in Q1 2026 from $30,767,000 in Q1 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1047335/000143774926015802/ex_958378.htm"></span></p><h4>Other Financial Items</h4><p>Non-operating income was $3,757,000 in Q1 2026, down from $4,079,000 in Q1 2025. Interest expense significantly decreased to - $269,000 in Q1 2026 from - $2,106,000 in Q1 2025. Unrealized gains on marketable equity securities were $9,074,000 in Q1 2026 compared to $10,982,000 in Q1 2025. The income tax provision was - $8,712,000 in Q1 2026 versus - $11,432,000 in Q1 2025. Net income attributable to noncontrolling interest was - $246,000 in Q1 2026, compared to - $85,000 in Q1 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1047335/000143774926015802/ex_958378.htm"></span></p><h4>Balance Sheet Highlights</h4><p>As of March 31, 2026, cash, cash equivalents, and marketable securities were $258,352,000, up from $255,801,000 at December 31, 2025. Restricted cash, cash equivalents, and marketable securities were $160,258,000, compared to $159,848,000. Total assets were $1,524,094,000, slightly down from $1,526,419,000. Current and long-term debt decreased from $40,000,000 at December 31, 2025, to $0 at March 31, 2026. National HealthCare Corporation stockholders’ equity increased to $1,090,949,000 from $1,068,772,000.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1047335/000143774926015802/ex_958378.htm"></span></p><h4>Selected Operating Statistics</h4><p>Average Skilled Nursing Per Diem increased to $371.69 in 2026 from $360.14 in 2025. Total Skilled Nursing Patient Days increased to 724,456 in 2026 from 718,136 in 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1047335/000143774926015802/ex_958378.htm"></span></p><h4>Outlook / Guidance</h4><p>The report includes forward-looking statements regarding risks and uncertainties detailed in SEC filings, but it does not provide specific financial guidance or outlook for future periods.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1047335/000143774926015802/ex_958378.htm"></span></p>

National Healthcare | 8-K: FY2026 Q1 Revenue: USD 381.82 M